A Reuters article republished by Bangkok Post titled, “Thailand to make, supply AstraZeneca’s Covid-19 vaccine” would claim that Thailand has agreed to make AstraZeneca’s COVID-19 vaccine.
This is despite the vaccine not only not having passed clinical trials or having been determined to be safe or effective yet – but despite AstraZeneca’s long history of corruption, bribery, and the overall danger of Western pharmaceutical giants who use lobbying to push dangerous, unnecessary products past regulators and onto the public.
AstraZeneca’s vaccine has already made news by possibily creating neurological disorders in patients involved in clinical trials.
CNN in an article titled, “Internal AstraZeneca safety report sheds light on neurological condition suffered by vaccine trial participant,” would report (emphasis added):
CNN has obtained an internal safety report by pharmaceutical giant AstraZeneca that sheds light on the neurological condition suffered by one of the participants in its coronavirus vaccine clinical trial.
The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5.
While both AstraZeneca and Western regulators dismissed the incident – it is not certain whether this is because the condition was truly unrelated to the ongoing vaccine trial – or because AstraZeneca simply bribed regulators to ignore it.
It is unclear because AstraZeneca along with the entirety of the Western pharmaceutical industry are notoriously corrupt and each investigated and fined multiple times around the globe for massive bribery campaigns aimed at everything from boosting sales, to having dangerous products approved for sale, to money paid to close investigations into their business practices or the dangers their products present to the public’s health.
Reuters Report on AstraZeneca
AstraZeneca – developing its candidate for a COVID-19 vaccine with billions in US government funding – is guilty – not suspected of or accused of – but guilty of bribery in multiple countries and has been fined by the US government itself.
Reuters in its article, “AstraZeneca to pay $5.52 million to resolve SEC foreign bribery case,” would report: